Valuation: BOIRON

Capitalization 534M 621M 500M 466M 861M 55.9B 937M 5.85B 2.26B 26.4B 2.33B 2.28B 96.53B P/E ratio 2025 *
19.7x
P/E ratio 2026 * 14.9x
Enterprise value 430M 500M 403M 375M 694M 45.03B 754M 4.71B 1.82B 21.27B 1.88B 1.84B 77.75B EV / Sales 2025 *
0.85x
EV / Sales 2026 * 0.75x
Free-Float
12.92%
Yield 2025 *
2.03%
Yield 2026 * 2.67%
More valuation ratios * Estimated data
Dynamic Chart
1 day-3.00%
1 week+7.89%
Current month+7.89%
1 month+10.22%
3 months+33.99%
6 months+33.70%
Current year+14.74%
More quotes
1 week 27.65
Extreme 27.65
32.25
1 month 25.55
Extreme 25.55
32.25
Current year 20.85
Extreme 20.85
32.25
1 year 20.85
Extreme 20.85
32.25
3 years 20.85
Extreme 20.85
56.5
5 years 20.85
Extreme 20.85
56.5
10 years 20.85
Extreme 20.85
92.91
More quotes
Manager TitleAgeSince
Chief Executive Officer 56 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 80 1987-05-05
Director/Board Member 80 1996-09-17
Director/Board Member 53 2010-03-09
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-3.00%+7.89%+15.82%-31.74% 621M
+0.51%-0.09%-17.70%-30.55% 6.48B
+0.26%+2.22%+45.15%+57.01% 4.39B
+0.80%+1.65%-16.45%+23.49% 4.37B
+0.06%-2.57%+6.87%-59.26% 4.3B
-0.26%+4.07%-7.48%-10.98% 3.56B
+0.20%+0.13%+5.50%+32.21% 3.24B
+0.30%-0.06%-0.82%-30.63% 2.53B
-0.40%+0.16%+9.85%+3.00% 1.99B
-0.09%+0.96%-0.90%+60.48% 1.76B
Average -0.16%+0.18%+3.98%+1.30% 3.32B
Weighted average by Cap. +0.18%-0.53%+1.76%-0.58%
See all sector performances

Financials

2025 *2026 *
Net sales 505M 587M 473M 441M 814M 52.83B 885M 5.53B 2.13B 24.95B 2.2B 2.16B 91.24B 522M 608M 489M 456M 842M 54.68B 916M 5.72B 2.21B 25.83B 2.28B 2.23B 94.43B
Net income 27.34M 31.81M 25.61M 23.87M 44.1M 2.86B 47.96M 300M 116M 1.35B 119M 117M 4.94B 36.06M 41.96M 33.79M 31.49M 58.16M 3.78B 63.26M 395M 153M 1.78B 157M 154M 6.52B
Net Debt -104M -121M -97.27M -90.67M -167M -10.87B -182M -1.14B -439M -5.13B -453M -444M -18.77B -143M -166M -134M -125M -231M -14.98B -251M -1.57B -605M -7.07B -625M -611M -25.87B
More financial data * Estimated data
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (44.8%), Europe (25.3%), North America (25.9%) and other (4%).
Employees
2,736
More about the company
Date Price Change Volume
25-12-05 30.75 -3.00% 858
25-12-04 31.70 +7.09% 4,263
25-12-03 29.60 0.00% 1,326
25-12-02 29.60 +1.72% 1,226
25-12-01 29.10 +2.11% 3,242

Real-time Euronext Paris, December 05, 2025 at 11:55 am EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
30.75EUR
Average target price
25.00EUR
Spread / Average Target
-18.70%
Consensus

Annual profits - Rate of surprise